$MRK News Article - Merck's KEYTRUDA (pembrolizum
Post# of 151
(Total Views: 480)
Posted On: 12/20/2019 12:05:43 PM
$MRK News Article - Merck's KEYTRUDA (pembrolizumab) Approved in Japan for Three New First-Line Indications Across Advanced Renal Cell Carcinoma (RCC) and Recurrent or Distant Metastatic Head and Neck Cancer https://marketwirenews.com/news-releases/merc...67956.html
(0)
(0)Merck & Co. Inc. (MRK) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼